Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes

    In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ...

    View Details

  • A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

    The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...

    View Details

  • EVALUATION OF FREQUENCY ALLOCATION TABLES FOR RECENTLY IMPLANTED SINGLE-SIDED DEAF COCHLEAR IMPLANT USERS

    This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ...

    View Details

  • The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents

    The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment ...

    View Details

  • Duration and Efficacy of Azstarys (serdexmethylphenidate and dexmethylphenidate) on Adult ADHD Symptoms and Executive Function In Early Evening

    The purpose of this open-label treatment study is to extend the safety and efficacy evidence basis for Azstarys, a recently FDA approved ADHD product, in ...

    View Details

  • Compassionate Use of Pirtobrutinib for a Patient with Waldenstrom s macroglobulinemia.

    You can participate in this study if you are diagnosed with Waldenstrom’s macroglobulinemia. In this study we will evaluate the study drug (Pirtobrutinib) for ...

    View Details

  • Randomized multicenter open-label phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRa-positive recurrent platinum-sensitive ovarian cancer

    This study is designed for patients diagnosed with FRa-positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers after second line platinum-based chemotherapy plus ...

    View Details

  • A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy ASSIST Study

    The purpose of the study is to assess the effectiveness of a remote monitoring system to improve compliance to medical treatment, improve clinical outcomes (symptoms ...

    View Details